M7824 in Combination With Chemotherapy in Stage IV Non-small Cell Lung Cancer (NSCLC)
Condition: Carcinoma, Non-Small-Cell Lung Interventions: Drug: Cisplatin; Drug: Carboplatin; Drug: Pemetrexed; Drug: Nab-paclitaxel; Drug: Gemcitabine; Drug: Docetaxel; Drug: M7824 Sponsors: EMD Serono Research & Development Institute, Inc.; Merck KGaA, Darmstadt, Germany Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Alimta | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Docetaxel | Germany Health | Lung Cancer | Non-Small Cell Lung Cancer | Research | Taxotere